About Qualigen Therapeutics, Inc. - Common Stock (QLGN)
Qualigen Therapeutics Inc is a biotechnology company focused on developing and commercializing innovative therapies and diagnostics for various medical conditions. Its primary mission is to enhance healthcare solutions through its proprietary technologies, particularly in the fields of oncology and infectious diseases. The company offers a range of products, including its advanced diagnostic platforms that aim to facilitate quicker and more accurate disease detection, as well as therapeutic candidates designed to improve treatment outcomes for patients facing serious health challenges. Through its cutting-edge research and development efforts, Qualigen seeks to contribute to the future of personalized medicine and improve the quality of life for patients worldwide. Read More
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outstanding shares is at $87.2 million.
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy”), a fast-growing consumer health and wellness company, today announced two major leadership appointments to accelerate growth in the $100 billion+ global functional beverage and energy drink market .
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
LOS ANGELES and CARLSBAD, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, and Qualigen Therapeutics, Inc. (NASDAQ: QLGN) ("QLGN"), jointly announced that they have entered into a securities purchase agreement (the “Agreement”) for a private investment in public equity (PIPE) in QLGN’s common stock and preferred stock, and will start a crypto and web3-related business.
Let's delve into the US markets on Wednesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
